Article
Envision Pharma Group
Season 2, Episode 18: Turning the Page with Chadi Nabhan
Join Michael Pietrack on the Pharmaverse Podcast as he sits down with Dr. Chadi Nabhan, MD – CMO and Head of Strategy at RyghtAI, hematologist, oncologist, author, and podcast host – to explore the future of clinical trials, AI innovation, and leadership in healthcare.
In this episode, Dr. Nabhan shares:
✔️How RyghtAI uses AI digital twins to speed up clinical trials and reduce costs.
✔️The process of matching clinical trial protocols to the best sites worldwide.
✔️Lessons learned from mentorship, leadership, and his medical career.
✔️Insights from his books, including Toxic Exposure and The Cancer Journey.
✔️Strategies for balancing executive roles, healthcare innovation, and family life.
Whether you’re interested in AI in healthcare, clinical research, or leadership in biotech, this conversation is full of practical advice and inspiring stories.
Related Topics
You May Also Like
Envision Pharma Group
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
Article
iNIZIO